XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained (Deficit) Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Dec. 31, 2019   37,679,000        
Beginning Balance at Dec. 31, 2019 $ 175.5 $ 0.4 $ 189.7 $ (20.4) $ 2.8 $ 3.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 1.0   1.0      
Issuance of restricted stock (in shares)   36,000        
Issuance of restricted stock 0.0   (0.6) 0.6    
Stock withheld for employee taxes (in shares)   (15,000)        
Stock withheld for employee taxes (0.3)     (0.3)    
Proceeds from issuance of common stock (in shares)   30,000        
Proceeds from issuance of common stock 0.3   (0.2) 0.5    
Issuance of shares under employee stock purchase plan (in shares)   23,000        
Issuance of shares under employee stock purchase plan 0.4   0.4      
Dividends (43.3)       (43.3)  
Purchase of treasury shares (in shares)   (233,000)        
Purchase of treasury shares (3.9)     (3.9)    
Change in cumulative translation adjustment (0.2)         (0.2)
Net income 8.2       8.2  
Ending Balance (in shares) at Mar. 31, 2020   37,520,000        
Ending Balance at Mar. 31, 2020 137.7 $ 0.4 190.3 (23.5) (32.3) 2.8
Beginning Balance (in shares) at Dec. 31, 2019   37,679,000        
Beginning Balance at Dec. 31, 2019 $ 175.5 $ 0.4 189.7 (20.4) 2.8 3.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Purchase of treasury shares (in shares) (283,450)          
Purchase of treasury shares $ (4.8)          
Change in cumulative translation adjustment (0.2)          
Net income 24.6          
Ending Balance (in shares) at Jun. 30, 2020   37,475,000        
Ending Balance at Jun. 30, 2020 148.7 $ 0.4 191.0 (24.3) (21.2) 2.8
Beginning Balance (in shares) at Mar. 31, 2020   37,520,000        
Beginning Balance at Mar. 31, 2020 137.7 $ 0.4 190.3 (23.5) (32.3) 2.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 0.8   0.8      
Issuance of restricted stock (in shares)   5,000        
Issuance of restricted stock 0.0   (0.1) 0.1    
Dividends $ (5.3)       (5.3)  
Purchase of treasury shares (in shares) (50,201) (50,000)        
Purchase of treasury shares $ (0.9)     (0.9)    
Change in cumulative translation adjustment 0.0          
Net income 16.4       16.4  
Ending Balance (in shares) at Jun. 30, 2020   37,475,000        
Ending Balance at Jun. 30, 2020 148.7 $ 0.4 191.0 (24.3) (21.2) 2.8
Beginning Balance (in shares) at Dec. 31, 2020   37,552,000        
Beginning Balance at Dec. 31, 2020 106.8 $ 0.4 193.5 (24.0) (66.5) 3.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 0.4   0.4      
Issuance of restricted stock (in shares)   65,000        
Issuance of restricted stock 0.0   (1.1) 1.1    
Stock withheld for employee taxes (in shares)   (47,000)        
Stock withheld for employee taxes (1.9)     (1.9)    
Proceeds from issuance of common stock (in shares)   119,000        
Proceeds from issuance of common stock 2.3   (0.2) 2.5    
Issuance of shares under employee stock purchase plan (in shares)   29,000        
Issuance of shares under employee stock purchase plan 0.5   0.5      
Dividends (6.0)       (6.0)  
Change in cumulative translation adjustment 0.1         0.1
Net income 15.2       15.2  
Ending Balance (in shares) at Mar. 31, 2021   37,718,000        
Ending Balance at Mar. 31, 2021 117.4 $ 0.4 193.1 (22.3) (57.3) 3.5
Beginning Balance (in shares) at Dec. 31, 2020   37,552,000        
Beginning Balance at Dec. 31, 2020 $ 106.8 $ 0.4 193.5 (24.0) (66.5) 3.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Purchase of treasury shares (in shares) 0          
Change in cumulative translation adjustment $ 0.2          
Net income 37.2          
Ending Balance (in shares) at Jun. 30, 2021   37,737,000        
Ending Balance at Jun. 30, 2021 134.5 $ 0.4 193.8 (21.9) (41.4) 3.6
Beginning Balance (in shares) at Mar. 31, 2021   37,718,000        
Beginning Balance at Mar. 31, 2021 117.4 $ 0.4 193.1 (22.3) (57.3) 3.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 1.0   1.0      
Issuance of restricted stock (in shares)   8,000        
Issuance of restricted stock 0.0   (0.1) 0.1    
Stock withheld for employee taxes (in shares)   (4,000)        
Stock withheld for employee taxes (0.1)     (0.1)    
Proceeds from issuance of common stock (in shares)   15,000        
Proceeds from issuance of common stock 0.2   (0.2) 0.4    
Dividends (6.1)       (6.1)  
Change in cumulative translation adjustment 0.1         0.1
Net income 22.0       22.0  
Ending Balance (in shares) at Jun. 30, 2021   37,737,000        
Ending Balance at Jun. 30, 2021 $ 134.5 $ 0.4 $ 193.8 $ (21.9) $ (41.4) $ 3.6